GlycoSyn seeks new customers for drug ingredient worth 20 times more than gold

GlycoSyn seeks new customers for drug ingredient worth 20 times more than gold
By Fiona Rotherham Nov. 5 (BusinessDesk) - GlycoSyn is seeking new global customers for kifunensine, a key ingredient in the manufacture of a drug for the treatment of rare genetic disorders that's worth 20 times more than gold on a per-gram basis. The drug research, development, and manufacturing unit of Callaghan Innovation is a world leader in carbohydrate chemistry and has sold more than $16 million of clinical grade kifunensine to a US-based biotech company in the past seven years. It is now marketing the ingredient to other pharma t...